iShares Nasdaq Biotechnology (IBB)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
- Barrons.com•22 hours ago
Raymond James analyst Christopher Raymond and team note that investors have started taking money out of biotech funds again: Flow of funds remains a key metric. Each week, we track the flow of funds into healthcare/biotech dedicated funds, as reported by Lipper/AMG Data Services. For the weekly period ending August 24, 2016, biotech saw net outflows of ~$184 million, representing a 0.36% decrease in assets.
- Benzinga•4 days ago
It’s been a rough week for Mylan NV (NASDAQ: MYL ). To stem the tide of criticism over price hikes of its EpiPen, CEO Heather Bresch went on CNBC Thursday to offer a "Savings Card" to consumers. ...
- Zacks•4 days ago
Mylan offers discounts to the purchase of EpiPen to cool down criticism over its steep price. How will biotech ETFs take this move?